Curriculum Vitaes

yu kato

  (加藤 由布)

Profile Information

Affiliation
Fujita Health University
Degree
修士(保建学)(藤田保健衛生大学大学院)

Researcher number
50773412
J-GLOBAL ID
201801005012134614
researchmap Member ID
B000313065

Research Interests

 3

Papers

 6
  • Yamashita C, Moriyama K, Hasegawa D, Kato Y, Sakai T, Kawaji T, Shimomura Y, Kurimoto Y, Nagata M, Nishida O
    Blood purification, 46(4) 269-273, Jul, 2018  Peer-reviewed
  • Takahiro Kawaji, Toshikazu Sakai, Kazuhiro Moriyama, Yoshitaka Hara, Tomoyuki Nakamura, Naohide Kuriyama, Yasuyo Shimomura, Yu Kato, Hidefumi Komura, Chizuru Yamashita, Yasuyoshi Kurimoto, Daisuke Hasegawa, Osamu Nishida
    Therapeutic Apheresis and Dialysis, 22(3) 290-294, Jun 1, 2018  Peer-reviewed
  • Yasuyo Shimomura, Mika Suga, Naohide Kuriyama, Tomoyuki Nakamura, Toshikazu Sakai, Yu Kato, Yoshitaka Hara, Chizuru Yamashita, Hiroshi Nagasaki, Masao Kaneki, Osamu Nishida
    Journal of Intensive Care, 4(1) 48, Jul 22, 2016  Peer-reviewed
  • Yoshitaka Hara, Yasuyo Shimomura, Tomoyuki Nakamura, Naohide Kuriyama, Chizuru Yamashita, Yu Kato, Taku Miyasho, Toshikazu Sakai, Shingo Yamada, Kazuhiro Moriyama, Osamu Nishida
    THERAPEUTIC APHERESIS AND DIALYSIS, 19(4) 308-315, Aug, 2015  Peer-reviewed
  • 西田修, 湯本美穂, 森山和広, 加藤由布, 下村泰代, 中村智之, 栗山英直, 原嘉孝, 伊藤舞, 野田昌宏, 秋山正慶, 早川聖子, 小松聖史, 山田晋吾, 宮庄拓
    日本アフェレシス学会雑誌, 31(2) 148-155, May 31, 2012  
  • Nishida Osamu, Yumoto Miho, Moriyama Kazuhiro, Kato Yu, Shimomura Yasuyo, Nakamura Tomoyuki, Kuriyama Naohide, Hara Yoshitaka, Ito Mai, Noda Masahiro, Akiyama Masayoshi, Hayakawa Seiko, Komatsu Satoshi, Yamada Shingo, Miyasho Taku
    日本アフェレシス学会雑誌, 31(2) 148-155, 2012  
    The high mobility group box 1 protein (HMGB1) is an alarmin that plays an important role in sepsis and has been recognized as a promising target with a wide therapeutic window ; however, no drugs or devices are currently in practical use. Here we demonstrate the removal capacity of HMGB1 using seven internationally available membranes in vitro. High cut-off (HCO) membrane showed lower clearance than the adsorbing-membranes such as PMMA and AN69ST. AN69ST showed the dramatically high adsorption clearance of 60 mL/min in dealing with 100 mL/min of test solution flow. Similar results were obtained in the case of plasma. Moreover, no saturation of HMGB1 on AN69ST was observed. For the treatment of septic shock, we have selected the high-volume, high flow modality using 2.1 m^2 PMMA dialyser, with sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA), for breaking the vicious cycle of mediators. In our study, subjects were enrolled as septic shock patients and most patients were in septic shock without renal failure. We demonstrated the effectiveness for septic shock and amazingly high clearance of HMGB1, IL-6. IL-8 and IL-10. Adsorption is a promising mechanism to remove large-molecular-weight cytokines such as HMGB1 effectively.

Presentations

 40

Research Projects

 1